Current state of endovascular treatment of femoro-popliteal artery disease

Vascular Medicine

Volumn 12, Issue 3, 2007, Pages 223-234

  Zeller, Thomas ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Angioplasty; Percutaneous intervention; Peripheral occlusive disease; Popliteal artery; Stent; Superficial femoral artery

Indexed keywords

CILOSTAZOL; CLOPIDOGREL; IRIDIUM 192; NAFTIDROFURYL; NITINOL; PACLITAXEL; PENTOXIFYLLINE; PROBUCOL; RAPAMYCIN; STAINLESS STEEL;

ANKLE BRACHIAL INDEX; ATHERECTOMY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRACHYTHERAPY; CLINICAL TRIAL; DRUG ELUTING STENT; ENDARTERECTOMY; EXCIMER LASER; FEMORAL ARTERY; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; LEG REVASCULARIZATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; STENT; TREADMILL EXERCISE;

ARTERIOSCLEROSIS; FEMORAL ARTERY; GUIDELINES AS TOPIC; HUMANS; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; VASCULAR SURGICAL PROCEDURES;

EID: 35848944671     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X07079823     Document Type: Review

References (98)

1. Newman AB, Shemanski L, Manolio TA et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999; 19: 538-45.
2. Diehm C, Schuster A, Allenberg JA et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: a cross-sectional study. Atherosclerosis 2004; 172: 95-105.
3. Weitz JL, Byrne J, Clagett GP et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996; 94: 3026-49.
4. Dormandy J, Mahir M, Ascady G et al. Fate of the patient with chronic leg ischemia: a review article. J Cardiovasc Surg (Torino) 1989; 30: 50-57.
5. McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 1989; 3: 273-77.
6. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, et al. Inter-Society Consensus for Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (1 suppl): S1-S75.
7. Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease 2005 (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive summary. J Am Coll Cardiol 2006; 47: 1239-312.
8. Pentacost MJ, Criqui MH, Dorros G et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. Circulation 1994; 89: 511-31.
9. Shouse HB, Nikanorov A, LaFlash D. Biomechanical forces in the femoropopliteal arterial segment. Endovascular Today 2005; 4: 60-66.
10. Dotter CT, Krippaehne WW, Judkins MP. Transluminal recanalization and dilatation in atherosclerotic obstruction of femoral popliteal system. Am Surg 1965; 31: 453-59.
11. Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology 1989; 170: 921-40.
12. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991; 83:I 70-I 80.
13. Murray JG, Apthorp LA, Wilkins RA. Long segment (> 10 cm) femoropopliteal angioplasty: improved technical success and long term patency. Radiology 1995; 195: 158-62.
14. Krepel VM, van Andel GJ, van Erp WF, Breslau PJ. Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiology 1985; 156: 325-28.
15. Clark TW, Groffsky JL, Soulen MC. Predictors of long term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 2001; 12: 923-33.
16. Bell P. Subintimal angioplasty. Presented at the International Congress XVII Endovascular Intervention. 9-12 February 2004. Scottsdale, USA.
17. Gordon IL, Conroy RM, Arefi M, Tobis JM, Stemmer EA, Wilson SE. Three-year outcome of endovascular treatment of superficial femoral artery occlusion. Arch Surg 2001; 136: 221-28.
18. Damaraju S, Cuasay L, Le D, Strickman N, Krajcer Z. Predictors of primary patency failure in Wallstent self-expanding endovascular prostheses for iliofemoral occlusive disease. Tex Heart Inst J 1997; 24: 173-78.
19. Martin EC, Katzen BT, Benenati JF et al. Multicenter trial of the Wallstent in the iliac and femoral arteries. J Vasc Interv Radiol 1995; 6: 843-49.
20. Henry M, Amor M, Ethevenot G et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology 1995; 197: 167-74.
21. Strecker EP, Hagen B, Liermann D, Schneider B, Wolf HR, Wambsganss J. Iliac and femoropopliteal vascular occlusive disease treated with flexible tantalum stents. Cardiovasc Intervent Radiol 1993; 16: 158-64.
22. Bergeron P, Pinot JJ, Poyen V et al. Long-term results with the Palmaz stent in the superficial femoral artery. J Endovasc Surg 1995; 2: 161-67.
23. Vogelzang RL. Long term results of angioplasty. J Vasc Interv Radiol 1996; 7 (suppl): 179.
24. Henry M, Amor M, Henry I. Femoropopliteal stenting results, indications: choice of the stent. Radiology 1999; 213: 50-59.
25. Strecker EP, Boos IB, Gottmann D. Femoropopliteal artery stent placement: evaluation of long-term success. Radiology 1997; 205: 375-83.
26. Chatelard P, Guibourt C. Long-term results with a Palmaz stent in the femoropopliteal arteries. J Cardiovasc Surg 1996; 37: 67-72.
27. Cejna M, Thurnher S, Illiasch H et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001; 12: 23-31.
28. Zdanowsky Z, Albrechtsson U, Lundin A et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol 1999; 18: 251-55.
29. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997; 20: 420-25.
30. Hayerizadeh R, Zeller T, Krankenberg H et al. Long-term outcome of superficial femoral artery stenting using nitinol stents compared with stainless steel stents. A multicenter study. Am J Cardiol 2003; 92 (suppl): S157L.
31. Sabeti S, Schillinger M, Amighi J et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score adjusted analysis. Radiology 2004; 232: 516-21.
32. Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M. Primary patency of long-segment serf-expanding nitinol stents in the femoropopliteal arteries, J Endovasc Ther 2005; 12: 6-12.
33. Mewissen MW. Nitinol stents in the femoropopliteal arterial segment. Endovascular Today 2005; 4: 29-34.
34. Duda SH, Bosiers M, Lammer J et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005; 16: 331-38.
35. Duda SH, Bosiers M, Lammer J et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery. J Endovasc Ther 2006; 13: 701-10.
36. Scheinert D, Scheinert S, Sax J et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005; 45: 312-15.
37. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-88.
38. Krankenberg H on behalf of the FAST study group. The femoral artery stenting trial (FAST). 12-month final analysis. Presented at Transcatheter Cardiovascular Therapeutics 2006, 22-27 October 2006, Washington, DC, USA.
39. Ahmadi R, Schillinger M, Maca T et al. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology 2002; 223: 345-50.
40. Henry M, Amor M, Cragg A et al. Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system. Radiology 1996; 201: 717-24.
41. Kessel DO, Wijesinghe LD, Robertson I et al. Endovascular stent-grafts for superficial femoral artery disease: results of 1-year follow-up. J Vasc Interv Radiol 1999; 10: 289-96.
42. Rodriguez-Lopez JA, Soler L, Wemer A et al. Long-term follow-up of endoluminal grafting for aneurysmal and occlusive disease in the superficial femoral artery. J Endovasc Surg 1999; 6: 270-77.
43. Spoelstra H, Casselman F, Lesceu O. Balloon-expandable endobypass for femoropopliteal atherosclerotic occlusive disease. J Vasc Surg 1996; 24: 647-54.
44. Bauermeister G. Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease. J Endovasc Ther 2001; 8: 315-20.
45. Lammer J, Dake MD, Bleyn J et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology 2000; 217: 95-104.
46. Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft. J Endovasc Ther 2003; 10: 619-28.
47. Deutschmann HA, Schedlbauer P, Berczi V et al. Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol 2001; 12: 943-50.
48. Fischer M, Schwabe C, Schulte KL. Value of the Hemobahn/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 2006; 13: 281-90.
49. Jahnke T, Andresen R, Muller-Hulsbeck S et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol 2003; 14: 41-51.
50. Railo M, Roth WD, Edgren J et al. Preliminary results with endoluminal femoropopliteal thrupass. Ann Chir Gynaecol 2001; 90: 15-18.
51. Brodmann M, Stark G, Pabst E et al. Osteomyelitis of the spine and abscess formation in the left thigh after stent-graft implantation in the superficial femoral artery. J Endovasc Ther 2000; 7: 150-54.
52. Tielliu I, Verhoeven E, Prins T et al. Treatment of popliteal artery aneurysms with the Hemobahn stent-graft. J Endovasc Ther 2003; 10: 111-16.
53. Juergens KU, Tombach B, Reimer P et al. Perivascular inflammatory reaction to a Hemobahn stent-graft: diagnosis with 3D MR angiography. J Endovasc Ther 2002; 9: 912-16.
54. Kazemi S, Djelmami-Hani M, Gupta A, Tumuluri R, Shalev Y, Allaqaband S. One year patency rate of the VIABAHN stent-graft for chronic total occlusion or long high-grade stenosis of the superficial femoral artery. Am J Cardiol 2006; 98: 235-36M.
55. Kazemi S, Djelmami-Hani M, Tumuluri R et al. VIABAHN stent-graft for treatment of in-stent restenosis in femoropopliteal vascular occlusive disease, procedural outcome and one-year follow-up. Am J Cardiol 2006; 98: 236M.
56. Saxon AR, Coffman JM, Gooding JM, Ponce DJ. Endograft use in the femoral and popliteal arteries. Tech Vasc Interv Radiol 2004; 7: 6-15.
57. Henry M, Amor M, Cragg A et al. Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system. Radiology 1996; 201: 717-24.
58. Duda SH, Pusich B, Richter G et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six month results. Circulation 2002; 106: 1505-509.
59. Ansel GM, Sample NS, Botti III CF Jr et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv 2004; 61: 1-4.
60. Jordan WD, Taylor SM. SFA stenosis treated with cryoplasty. Endovascular Today 2004; 1: 31-33.
61. Jahnke T. Cryoplasty for the treatment of femoropopliteal artery disease: will freezing solve the problem of cold feet? J Vasc Interv Radiol 2005; 16: 1051-54.
62. Laird JR, Jaff MR, Biamino G et al. Cryoplasty for the treatment of femoro-popliteal arterial disease: results of a prospective multicenter registry. J Vasc Interv Radiol 2005; 16: 1067-73.
63. Dorros G, Iyer S, Lewin R et al. Angiographic follow-up and clinical outcome of 126 patients after percutaneous directional atherectomy (Simpson AtheroCath) for occlusive peripheral vascular disease. Cathet Cardiovasc Diagn 1991; 22: 79-84.
64. Vroegindeweij D, Tielbeek AV, Buth J et al. Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. J Vasc Surg 1995; 21: 255-69.
65. Zeller T, Krankenberg H, Reimers B et al. Initial clinical experience with a new percutaneous peripheral atherectomy device for the treatment of femoro-popliteal stenoses [in German]. Rofo 2004; 176: 70-75.
66. Zeller T, Rastan A, Schwarzwälder U et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experience. J Endovasc Ther 2004; 11: 676-85.
67. Zeller T, Rastan A, Schwarzwälder U et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 2006; 48: 1573-78.
68. Ramaiah V, Gammon R, Kiesz S et al. Midterm outcomes from the TALON registry: treating peripherals with Silverhawk: outcome collection. J Endovasc Ther 2006; 13: 592-602.
69. Ho GH, Moll FL, Joosten PP et al. The Moll-ring Cutter remote endarterectomy: preliminary experience with a new endovascular technique for treatment of occlusive superficial femoral artery disease. J Endovasc Surg 1995; 2: 278-87.
70. Nelson PR, Powell RJ, Proia RR et al. Results of endovascular superficial femoral endarterectomy. J Vasc Surg 2001; 34: 526-31.
71. Rosenthal D, Martin JD, Schubart PJ, Wellons ED, Shuler FW, Levitt AB. Remote superficial femoral artery endarterectomy. J Vasc Surg 2004; 40: 67-72.
72. Das TS. Percutaneous peripheral revascularization with excimer laser: equipment, technique and results. Lasers Med Sci 2001; 16: 101-107.
73. Scheinert D, Laird JR Jr, Schröder M et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther 2001; 8: 156-66.
74. Steinkamp HJ, Rademaker J, Wissgott C et al. Percutaneous transluminal laser angioplasty versus balloon dilation for treatment of popliteal artery occlusions. J Endovasc Ther 2002; 9: 982-98.
75. Gray BH, Laird JR, Ansel GM et al. Complex endovascular treatment for critical limb ischemia in poor surgical candidates: a pilot study. J Endovasc Ther 2002; 9: 599-604.
76. Laird JR, Zeller T, Gray BH et al for the LACI Investigators. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther 2006; 13: 1-9.
77. Laird JR. Peripheral excimer laser angioplasty (PELA) trial results. Presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 24-28 September 2005, Washington DC, USA.
78. Zeller T, Krankenberg H, Schwarzwälder U et al. Initial clinical experience with the 'Pathway PV™ atherectomy catheter. Am J Cardiol 2006; 98: 122M.
79. Böttcher HD, Schopohl B, Liermann D et al. Endovascular irradiation: a new method to avoid recurrent stenosis after stent implantation in peripheral arteries - technique and preliminary results. Int J Radiat Oncol Biol Phys 1994; 29: 183-86.
80. Liermann DD, Bauernsachs R, Schopohl B et al. Intravascular irradiation therapy. In: Waksman R, editor. Vascular brachytherapy. 2nd ed. Armonk, NY Futura Publishing; 1999. p. 395-405.
81. Zehnder T, von Briel C, Baumgartner I et al. Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions. J Endovasc Ther 2003; 10: 304-11.
82. Gallino A, Do DD, Alerci M et al. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial. J Endovasc Ther 2004; 11: 595-604.
83. Bonvini R, Baumgartner I, Do DD et al. Late thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries. J Am Coll Cardiol 2003; 41: 409-12.
84. Waksman R, Laird JR, Jurkovitz CT et al. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Interv Radiol 2001; 12: 915-21.
85. Minar E, Pokrajac B, Ahmadi R et al. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology 1998; 208: 173-79.
86. Minar E, Pokrajac B, Maca T et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 2000; 102: 2694-99.
87. Pokrajac B, Schmid R, Pötter R et al. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 multicenter study [Abstract]. Int J Radiat Oncol Biol Phys 2003; 57 (2 suppl): S250.
88. Wolfram RM, Pokrajac B, Ahmadi R et al. Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. Radiology 2001; 220: 724-29.
89. Wolfram R, Pokrajac B, Budinsky AC et al. Vascular brachytherapy with 192Iridium after femoropopliteal stenting in high risk patients - results from the Vienna-5 trial. Z Kardiol 2003; 10 (suppl H): 19.
90. Tepe G, Zeller T, Albrecht T, Speck U. Local taxan with short time exposure for reduction of restenosis in distal arteries (THUNDER). Presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 22-27 October 2006, Washington DC, USA.
91. Scheller B, Hehrlein C, Bocksch W et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006; 355: 2113-24.
92. Zeller T, Frank U, Bürgelin K et al. Early experience with a rotational thrombectomy device for treatment of acute and subacute infraaortic arterial occlusions. J Endovasc Ther 2003; 10:322-31.
93. Duc SR, Schoch E, Pfyffer M, Jenelten R, Zollikofer CL. Recanalization of acute and subacute femoropopliteal artery occlusions with the Rotarex catheter: one year follow-up. Single center experience. Cardiovasc Intervent Radiol 2005; 28: 603-10.
94. Zeller T, Frank U, Bürgelin K et al. [Long-term results, after recanalization of acute and subacute thrombotic occlusions of the infra-aortic arteries and bypass grafts using a rotational thrombectomy device.] Article in German. Rofo 2002; 174: 1559-65.
95. Scheinert D, Biamino G. Access sites for peripheral interventions. In: Marco J, Serruys P, Biamino G et al, editors. The Paris Course on Revascularization course book. Europa Edition: Poitiers, France; 2003. p. 405-10.
96. Jaff MR. The nature of SFA disease. Endovascular Today 2004; Suppl 3: 5.
97. Wolford HY, Surowiec SM, Davies MG. SFA angioplasty versus femoropopliteal bypass. Endovascular Today 2005; 4: 51-53.
98. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease: a decision and cost effectiveness analysis. JAMA 1995; 274: 165-71.